As researchers race to develop a COVID-19 vaccine, a Rutgers infectious disease expert and a Rutgers bioethicist discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials and what a successful vaccine may mean.
As researchers try to develop therapies/vaccines to combat SARS-CoV-2, the coronavirus spike protein is a major focus since it can bind to cells. Now, researchers reporting in ACS Central Science have uncovered an active role for glycans in this process, suggesting targets for vaccines and therapies.
As Americans begin pulling up their sleeves for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternative vaccine approach that provides broader protection against seasonal influenza.
In an analysis of patients hospitalized with COVID-19, kidney damage associated with the infectious disease was linked with a higher risk of dying during hospitalization.
Mathematicians have developed a framework to determine when regions enter and exit COVID-19 infection surge periods, providing a useful tool for public health policymakers to help manage the coronavirus pandemic.
Researchers around the world are a step closer to a better understanding of the intricacies of COVID-19 thanks to two new web resources developed by investigators at Baylor College of Medicine and the University of California San Diego.
According to Jochen Reiser, MD, PhD, the Ralph C Brown MD professor and chairperson of Rush's Department of Internal Medicine, patients with COVID-19 experience elevated levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.
Using a combination of demographic and clinical data gathered from seven weeks of COVID-19 patient care early in the coronavirus pandemic, Johns Hopkins researchers today published a "prediction model" they say can help other hospitals care for COVID-19 patients -- and make important decisions about planning and resource allocations.
Achieving herd immunity to COVID-19 is an impractical public health strategy, according to a new model developed by University of Georgia scientists. The study recently appeared in Proceedings of the National Academy of Sciences.
U.S. cellphone data analysis finds "hotspots" where COVID-19 social distancing levels are low, as well as revealing how demographics and governmental restrictions interact.